
Experimental Treatments Aim to Prevent Brain Damage in Babies
Advances in neuroscience are driving the development of therapies that could save thousands of the most vulnerable patients
Erika Check Hayden works for Nature magazine.

Experimental Treatments Aim to Prevent Brain Damage in Babies
Advances in neuroscience are driving the development of therapies that could save thousands of the most vulnerable patients

The Flip Side of Personal Genomics: When a Mutation Doesn't Spell Disease
Researchers worry about misinforming people about the risk of disease

Rwanda Feels the Pinch as Donors Slash Health Aid
Country's progress on public health and science prompts funding shift to more-troubled nations

Ebola Virus Lingers Longer Than Scientists Thought
In one case, a nine-month-old child died from Ebola virus infection after her seemingly healthy mother passed the virus to her in breast milk

Most Extensive Reengineering of an Organism’s Genetic Code Now Complete
The feat, which radically altered Escherichia coli’s DNA, may be a big step forward for synthetic biology

Promising Gene Therapies Pose Million-Dollar Conundrum
Economists, investors and medical insurers can’t figure out how to pay for cutting-edge drugs

Myriad Genetics Embroiled in Breast-Cancer Data Fight—Again
Patients say the diagnostics company violated their rights to their own genetic data

Antibody Infusions Provide Long-Term Defense against HIV-Like Infection
Specialized proteins can protect monkeys against the virus for months

Dengue Vaccine Aces Trailblazing Trial
Protection against virus raises hopes of vaccine development for dengue and even Zika

Ebola Survivor's Blood Holds Promise of New Treatment
An antibody from a man who survived infection from the 1995 outbreak shows potent effect against deadly virus

Unusual Deal Ensures Ebola Vaccine Supply
Drugmaker commits to stockpiling 300,000 doses and beginning approval process

Ebola Experience Leaves World No Less Vulnerable
Report concludes that not enough has changed nearly two years after the start of the catastrophic west Africa epidemic

Why Biomedical Superstars Are Signing On with Google
Tech firm’s ambitious goals and abundant resources attract life scientists, most recently Harvard Medical School cardiologist Jessica Mega

Ebola Survivors Fight Prejudice
Organizations seek to help patients reintegrate into society after recovering

Ebola: An Eyewitness Account from Sierra Leone, Dec. 7
Nature reports from the front line of the outbreak

Science Looks into Immortal Pets
A new experiment will study life span extension via an antiaging drug administered to domestic dogs

Many Mysteries Still Surround Ebola
The virus that causes Ebola is well understood but puzzling issues remain on topics such as the disease's lethality and whether the virus can be stopped

Protest Sparked as Louisiana Seeks to Ban Doctors Returned from West Africa
The response to Ebola could be undermined as Louisiana officials ask that doctors and researchers recently returned from three west African nations not attend the American Society of Tropical Medicine and Hygiene meeting November 2 to 6

Ebola Outbreak Shuts Down Malaria-Control Efforts
Public health experts fear that one epidemic may fuel another in West Africa

Vaginal Microbe Yields Novel Antibiotic
A new drug is one of thousands of drug-like molecules that may be produced by our microbiome

Ebola Drug Saves Infected Monkeys
ZMapp is the first treatment to completely protect animals after they show symptoms of disease

Drug Saves Monkeys from Ebola-Like Virus
The animals were spared from Marburg virus even when treated three days after infection

Ebola Declared a Public Health Emergency
The World Health Organization's announcement could shift the focus to basic public health

Uniter of Sperm and Egg Is Found
A newly discovered protein is found to play a crucial role in conception